Vaccines offer a way out of the Covid-19 pandemic, but only if there is universal and equitable access to those vaccines worldwide. Lack of transparency along the vaccine value chain – in research and development, manufacturing, distribution, and contracting – has contributed to vaccine access that is highly unequal, favouring the rich countries. Urgent action is needed to ensure greater transparency and contribute to securing fair access to Covid-19 vaccines around the world.

Recent CMI publications: